Breast-conserving therapy and sentinel lymph node biopsy are feasible in cancer patients with previous implant breast augmentation

Richard J. Gray, Adrienne W. Forstner-Barthell, Barbara A. Pockaj, Steven E. Schild, Michele Y. Halyard

Research output: Contribution to journalArticle

47 Scopus citations

Abstract

Background Breast-conserving therapy (BCT) is reported to result in a significant rate of complications and local recurrences in patients with prior implant breast augmentation. The role of sentinel lymph node (SLN) biopsy in these patients is unknown. Methods Retrospective review of patients with prior breast augmentation treated with BCT or SLN biopsy. Results Nineteen breast cancers were treated with BCT. Of 17 breasts undergoing adjuvant radiotherapy, 11 (64.7%) retained favorable aesthetic results. Of 9 subpectoral implants, capsular contracture developed in only 1 (11.1%). During follow-up (median 3 years), 1 local recurrence (5.3%) occurred in a patient who refused adjuvant radiotherapy and systemic therapy. Eleven patients underwent SLN biopsy with an identification rate of 100% and a false-negative rate of 0%. Conclusions Breast-conserving therapy inclusive of radiotherapy after implant breast augmentation produced acceptable cosmetic results in nearly two-thirds of patients. Sentinel lymph node mapping in the setting of prior implant augmentation was highly successful and accurate.

Original languageEnglish (US)
Pages (from-to)122-125
Number of pages4
JournalAmerican journal of surgery
Volume188
Issue number2
DOIs
StatePublished - Aug 2004

Keywords

  • Breast implants
  • Radiotherapy
  • Sentinel lymph node

ASJC Scopus subject areas

  • Surgery

Fingerprint Dive into the research topics of 'Breast-conserving therapy and sentinel lymph node biopsy are feasible in cancer patients with previous implant breast augmentation'. Together they form a unique fingerprint.

  • Cite this